
BIIB
Healthcare · Drug Manufacturers - General · $37.46B market cap
$253.40+2.92 (+1.2%)Nov 13, 4:15 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -13.4% over 90 days · 30-day revisions 1 up, 22 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 28, 2026 | Before the open | 2.06 | 2.62 | +27.2% |
| Jul 29, 2026 | Before the open | 3.04 | 3.60 | +18.4% |
| Apr 29, 2026 | Before the open | 2.89 | 3.57 | +23.5% |
| Feb 6, 2026 | Before the open | 1.62 | 1.99 | +22.8% |
| Oct 30, 2025 | Before the open | 3.88 | 4.81 | +24.0% |
| Jul 31, 2025 | Before the open | 3.88 | 5.47 | +41.0% |
| May 1, 2025 | Before the open | 2.95 | 3.02 | +2.4% |
| Feb 12, 2025 | Before the open | 3.36 | 3.44 | +2.4% |
| Oct 30, 2024 | Before the open | 3.79 | 4.08 | +7.7% |
| Aug 1, 2024 | Before the open | 4.03 | 5.28 | +31.0% |
| Apr 24, 2024 | Before the open | 3.46 | 3.67 | +6.1% |
| Feb 13, 2024 | Before the open | 3.18 | 3.30 | +3.8% |
| Nov 8, 2023 | Before the open | 3.98 | 4.36 | +9.5% |
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an…
| Jul 25, 2023 | Before the open | 3.76 | 4.02 | +6.9% |
| Apr 25, 2023 | Before the open | 3.28 | 3.40 | +3.7% |
| Feb 15, 2023 | Before the open | 3.48 | 4.05 | +16.4% |
| Oct 25, 2022 | Before the open | 4.13 | 4.77 | +15.5% |
| Jul 20, 2022 | Before the open | 4.07 | 5.25 | +29.0% |
| May 3, 2022 | Before the open | 4.36 | 3.62 | -17.0% |
| Feb 3, 2022 | Before the open | 3.37 | 3.39 | +0.6% |
| Oct 20, 2021 | Before the open | 4.10 | 4.77 | +16.3% |
| Jul 22, 2021 | Before the open | 4.60 | 5.68 | +23.5% |
| Apr 22, 2021 | Before the open | 4.94 | 5.34 | +8.1% |
| Feb 3, 2021 | Before the open | 4.80 | 4.58 | -4.6% |
| Oct 21, 2020 | Before the open | 8.05 | 8.84 | +9.8% |
| Jul 22, 2020 | Before the open | 8.00 | 10.26 | +28.3% |
| Apr 22, 2020 | Before the open | 7.69 | 9.14 | +18.9% |
| Jan 30, 2020 | Before the open | 8.08 | 8.34 | +3.2% |
| Oct 22, 2019 | Before the open | 8.27 | 9.17 | +10.9% |
| Jul 23, 2019 | Before the open | 7.53 | 9.15 | +21.5% |
| Apr 24, 2019 | Before the open | 6.96 | 6.98 | +0.3% |
| Jan 29, 2019 | Before the open | 6.72 | 6.99 | +4.0% |
| Oct 23, 2018 | Before the open | 6.76 | 7.40 | +9.5% |
| Jul 24, 2018 | Before the open | 5.14 | 5.80 | +12.8% |
| Apr 24, 2018 | Before the open | 5.94 | 6.05 | +1.9% |
| Jan 25, 2018 | Before the open | 5.45 | 5.26 | -3.5% |